The global nutrigenomics market is estimated to be valued at USD 1.47 billion in 2025 and is on a trajectory of rapid expansion. Projections indicate USD 3.50 billion valuation by 2032, exhibiting a CAGR of 13.2% during the forecast period.
Key factors driving this expansion include growing consumer interest in personalized nutrition, advancements in genomics and bioinformatics technologies, and increasing prevalence of diet-related chronic diseases. Additionally, heightened awareness about the role of gene-diet interactions in health optimization is propelling research initiatives and product innovations in the nutrigenomics space.
Key Market Takeaways:
The full report is now available for purchase: https://www.coherentmi.com/industry-reports/nutrigenomics-market
Nutrigenomics Market Report Coverage
|
Report Coverage |
Details |
|
Market Revenue in 2024 |
USD 1.47 billion |
|
Estimated Value by 2031 |
USD 3.50 billion |
|
Growth Rate |
Poised to exhibit a CAGR of 13.2% |
|
Historical Data |
2020–2024 |
|
Forecast Period |
2025–2032 |
|
Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
By Type of Sample and By Type of Sample Collection Method |
|
Geographies Covered |
North America (U.S. and Canada), Latin America (Brazil, Argentina, Mexico and Rest of Latin America), Europe (Germany, U.K., Spain, France, Italy, Russia and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN and Rest of Asia Pacific), Middle East (GCC Countries, Israel, Rest of Middle East), and Africa (South Africa, North Africa, and Central Africa) |
|
Growth Drivers |
|
|
Opportunities |
|
|
Trends |
|
|
Restraints & Challenges |
|
Market Dynamics
The nutrigenomics market growth is driven primarily by rising demand for tailored nutrition that is fueled by technological advancements in genetic research as well as greater consciousness of diet-gene interaction. With consumers shifting more to preventive medicine, the ability to tailor dietary counsel based on the individual's gene makeup is growing in significance. This is also supplemented by the rising prevalence of lifestyle disorders, such as obesity, diabetes, and cardiovascular disease, which are causing individuals to seek more targeted, data-driven health solutions.
The integration of DNA-based information in day-to-day nutrition planning enables consumers to tailor diets based on genetic inclination, resulting in overall health outcomes. Personalization eliminates the trial-and-error nature of nutrition and provides for improved, longer-lasting health care. Increasing availability of home genetic testing kits is also a main driver, improving access and driving mass-market adoption of nutrigenomics-based products.
As a results, companies are leveraging this demand by launching innovative services. For instance, in May 2024, Indian genealogy platform iMeUsWe, in partnership with MapMyGenome, introduced at-home DNA testing kits that offer insights into ancestry, health risks, and lifestyle-related genetic traits. The service includes genetic counseling and evaluates predispositions to conditions such as heart disease, neurological disorders, skin and hair issues, autoimmune diseases, and cancer. These developments underscore the growing potential of nutrigenomics as a cornerstone of personalized, preventive healthcare.
Market Trends
The adoption of AI-driven analytics in nutrigenomics is improving the accuracy of personalized diet recommendations. Companies are leveraging machine learning to analyze genetic data and provide customized nutrition plans.
For instance, in February 2025, researchers introduced NutriGen, a system utilizing large language models (LLMs) to generate personalized meal plans. By integrating user preferences, dietary restrictions, and nutritional databases, NutriGen offers scalable and adaptable dietary recommendations. Its evaluation demonstrated high accuracy in aligning meal plans with user-defined caloric targets
Governments and private organizations are increasingly investing in preventive health solutions, incorporating nutrigenomics into wellness programs. This aligns with the global shift towards precision medicine to prevent lifestyle diseases. In December, 2024, the USDA announced a $4.5 million investment to establish three additional Nutrition Hubs at the University of Hawaii, Texas A&M AgriLife Research, and Utah State University. These hubs will focus on providing tailored, science-based nutrition information to priority communities, including Tribal, Hispanic, and Insular Areas. They will also work to address structural inequalities and improve equitable access to health-promoting foods.
Market Opportunities
The growing interest in personalized nutrition is significantly driving the expansion of the nutrigenomics market. Consumers are increasingly seeking tailored dietary recommendations based on their genetic profiles to optimize health outcomes and manage chronic diseases. This shift towards individualized nutrition is supported by advancements in genomic technologies and a deeper understanding of gene-diet interactions.
In April 2025, Nourish, a healthcare startup, achieved a valuation exceeding $1 billion following a $70 million Series B funding round led by JP Morgan Growth Equity. The company connects patients with registered dietitians for virtual, insurance-covered nutritional care, employing over 3,000 dietitians. Nourish differentiates itself by hiring dietitians as full-time employees and investing heavily in AI to support both patients and clinicians. Its GLP-1 companion program aids weight-loss drug users with nutrition support, improving outcomes and reducing side effects. The company plans to use the new capital to expand staff, enhance AI tools, and grow partnerships.
The increasing consumer interest in health and wellness presents an opportunity for companies to create functional foods enriched with nutrients tailored to specific genetic profiles. This approach can aid in disease prevention and health optimization. In 2024, In 2024, Probi launched Probi Sensia, a probiotic product targeting mood, sleep, and stress. It utilizes the Lactiplantibacillus plantarum HEAL9 strain to support mental well-being.
Analyst View
"The nutrigenomics market is experiencing a pivotal transformation, driven by surging demand for personalized nutrition and advancements in genomic technologies," said Ms. Sakshi Suryawanshi, a senior market analyst. "As consumers increasingly recognize the role of gene-diet interactions in health optimization, the integration of genetic insights into routine dietary planning is becoming mainstream."
"The growing accessibility of at-home DNA testing kits and digital health platforms is democratizing genomic nutrition insights, paving the way for mass adoption. Companies like Nourish and iMeUsWe are redefining the personalized nutrition landscape by leveraging AI and telehealth services, providing scalable and evidence-based solutions. Furthermore, the development of nutrigenomic-based functional foods reflects a shift towards precision health and proactive disease prevention."
Recent Developments
Competitor Insights
Key players in the nutrigenomics market include:
Market Segmentation
Regional Insights
Related Reports :